The most recent retraction appears in the Journal of Biological Chemistry. Although, in typical JBC fashion, the reason for it is anyone’s guess.
Here’s the unhelpful notice for “ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1:”
This article has been withdrawn by the authors.
Although the journal offers no explanation for the retraction, some comments on PubPeer suggest problems with the figures. One commenter who claims to be the corresponding author acknowledged the errors and reportedly passed them onto the journal. The paper has been cited 66 times, according to Thomson Scientific’s Web of Knowledge.
The retraction was preceded by another from the group, of “Histone H2B Ubquitination Regulates Retinoic Acid Signaling through the Cooperation of ASXL1 and BAP1” from Molecular Cell in 2013. According to the notice, this 2013 paper was felled by “several manipulations” of Western blot data:
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
Soon after online publication of our paper we became aware of several manipulations of our Western blot data. In light of this, we are retracting the paper. We will continue to examine whether the central findings of the paper still stand; if they do, we will communicate them again in the future. We deeply apologize for any inconvenience that we may have caused.
The paper, which was published just a month before being retracted, has been cited three times.
We’ve asked Eu-Joo Kim andthe corresponding authors of the JBC paper for more details, and will update with anything we learn.
Like Retraction Watch? Consider supporting our growth. You can also follow us on Twitter, like us on Facebook, add us to your RSS reader, and sign up on our homepage for an email every time there’s a new post.